IBEX Technologies Inc.
IBT
Clasificación en acciones
#28820
Founded in 1972 and based in Montreal, Canada, IBEX Technologies Inc.... Founded in 1972 and based in Montreal, Canada, IBEX Technologies Inc. specializes in the production and global distribution of enzymes tailored for biomedical applications. The company's reach extends to Canada, the United States, Germany, and the United Kingdom, as well as other international markets. Its extensive product catalog features recombinant glycosaminoglycan lyases, such as Heparinase I, II, and III, along with Chondroitinase AC and B. Furthermore, IBEX offers collagen ELISAs designed to investigate the synthesis and breakdown of connective tissue components, complementing these with collagen antibodies and diamine oxidase liquid. They are also a key provider of arthritis assays, essential for research into osteoarthritis. Beyond their product lines, IBEX delivers lyophilization services for disposable medical device parts, in addition to custom fermentation and contract manufacturing capabilities. Their diverse client base encompasses medical device fabricators, quality control facilities, producers of low molecular weight heparin, and academic research institutions.
Precio por acción
$1.05
Última sincronización: 2024-04-11
Capitalización bursátil
$23.31M
Cambio (1 día)
-0.01%
Cambio (1 año)
5.21%
País
CA
Comercio IBEX Technologies Inc. (IBT)
Categoría
Healthcare
Capitalización de mercado de IBEX Technologies Inc.(IBT)
Capitalización bursátil: $23.31M
A fecha de October 2026, IBEX Technologies Inc. tiene una capitalización de mercado de $23.31M. Esto convierte a IBEX Technologies Inc. en la 28820th empresa más valiosa del mundo por capitalización bursátil, según nuestros datos. La capitalización bursátil es el valor total de mercado de las acciones en circulación de una empresa que cotiza en bolsa y se utiliza comúnmente para medir su valor.
Historial de capitalización de mercado de IBEX Technologies Inc. desde 2018 hasta 2026
IBT en comparación con los más populares 5 títulos stocks
